Andrea Gallamini

10PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targetsAnimal physiology - cellPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Aug 26, 2026
Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).

|Apr 04, 2025
Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine.

Malik E Juweid, Soud F Al-Qasem, Fadlo R Khuri

|Jul 23, 2024
Toward a paradigm shift in prognostication and treatment of early-stage Hodgkin lymphoma.

Andrea Gallamini, Andrea Filippi, Vincent Camus

|Oct 08, 2023
Revisiting the predictive role of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early-stage favorable Hodgkin lymphoma.

Andrea Gallamini, Axel Sudria, Michał Kurlapski

|Dec 10, 2022
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.

Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw

Pageof 2

Frequent Collaborators

3 joint publications

Stephane Chauvie

2 joint publications

David Hodgson

2 joint publications

Eric Mou

2 joint publications

Peter Johnson